The report provides a comprehensive analysis of the key players operating in the global antifungal drugs market, such as Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.
Chapter: 1 COMPANY PROFILES
1.1. PFIZER INC.
1.1.1. Company overview
1.1.2. Company snapshot
1.1.3. Operating business segments
1.1.4. Business performance
1.1.5. Key strategic moves and developments
1.2. SANOFI S.A
1.2.1. Company overview
1.2.2. Company snapshot
1.2.3. Operating business segments
1.2.4. Business performance
1.2.5. Key strategic moves and developments
1.3. GILEAD SCIENCES INC.
1.3.1. Company overview
1.3.2. Company snapshot
1.3.3. Operating business segments
1.3.4. Business performance
1.3.5. Key strategic moves and developments
1.4. MERCK & CO., INC.
1.4.1. Company overview
1.4.2. Company snapshot
1.4.3. Operating business segments
1.4.4. Business performance
1.4.5. Key strategic moves and developments
1.5. NOVARTIS INTERNATIONAL AG
1.5.1. Company overview
1.5.2. Company snapshot
1.5.3. Operating business segments
1.5.4. Business performance
1.5.5. Key strategic moves and developments
1.6. ABBOTT LABORATORIES
1.6.1. Company overview
1.6.2. Company snapshot
1.6.3. Operating business segments
1.6.4. Business performance
1.6.5. Key strategic moves and developments
1.7. BAYER AG
1.7.1. Company overview
1.7.2. Company snapshot
1.7.3. Operating business segments
1.7.4. Business performance
1.7.5. Key strategic moves and developments
1.8. SCYNEXIS INC.
1.8.1. Company overview
1.8.2. Company snapshot
1.8.3. Operating business segments
1.8.4. Business performance
1.8.5. Key strategic moves and developments
1.9. ENZON PHARMACEUTICALS INC.
1.9.1. Company overview
1.9.2. Company snapshot
1.9.3. Operating business segments
1.9.4. Business performance
1.9.5. Key strategic moves and developments
1.10. GLAXOSMITHKLINE PLC
1.10.1. Company overview
1.10.2. Company snapshot
1.10.3. Operating business segments
1.10.4. Business performance
1.10.5. Key strategic moves and developments
TABLE 1. PFIZER: COMPANY SNAPSHOT
TABLE 2. PFIZER: OPERATING SEGMENTS
TABLE 3. SANOFI: COMPANY SNAPSHOT
TABLE 4. SANOFI: OPERATING SEGMENTS
TABLE 5. GILEAD: COMPANY SNAPSHOT
TABLE 6. GILEAD: OPERATING SEGMENTS
TABLE 7. MERCK: COMPANY SNAPSHOT
TABLE 8. MERCK: OPERATING SEGMENTS
TABLE 9. NOVARTIS: COMPANY SNAPSHOT
TABLE 10. NOVARTIS: OPERATING SEGMENTS
TABLE 11. ABBOTT: COMPANY SNAPSHOT
TABLE 12. ABBOTT: OPERATING SEGMENTS
TABLE 13. BAYER: COMPANY SNAPSHOT
TABLE 14. BAYER: OPERATING SEGMENTS
TABLE 15. SCYNEXIS: COMPANY SNAPSHOT
TABLE 16. SCYNEXIS: OPERATING SEGMENTS
TABLE 17. ENZON: COMPANY SNAPSHOT
TABLE 18. ENZON: OPERATING SEGMENTS
TABLE 19. GSK: COMPANY SNAPSHOT
TABLE 20. GSK: OPERATING SEGMENTS
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers